Saturday, December 6, 2014

In an unusual move, the FDA takes issue with the accuracy of Sciecure's studies in a warning letter over sales promotion material for the company's sleeping pill .

  1. FDA Regulatory and Compliance Monthly Recap ... - JDSupra  

    www.jdsupra.com/.../fda-regulatory-and-compliance-monthly-re-85252/
    21 hours ago - In an unusual move, the FDA takes issue with the accuracy of Sciecure's studies in a warning letter over sales promotion material for the company's sleeping pill ...

No comments: